ONI is a pioneer of next generation super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision.
The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.
The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards.
More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.
ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.
The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.
The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards.
More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.
ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. We have a vision for making high tech science available to anyone, anywhere, from the research bench to your doctor’s office.
Location: United Kingdom, England, Oxford
Employees: 201-500
Total raised: $75M
Founded date: 2016
Investors 4
| Date | Name | Website |
| 26.03.2022 | ARCH Ventu... | archventur... |
| - | S32 | s32.com |
| - | Oxford Inv... | oxfordinve... |
| - | Oxford Sci... | oxfordscie... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.01.2022 | Series B | $75M | ARCH Ventu... |
Mentions in press and media 4
| Date | Title | Description |
| 13.03.2023 | Slone Partners Places Paul Scagnetti as Chief Executive Officer at ONI | “Paul Scagnetti is a tremendously experienced, driven, passionate business leader and visionary with both the strategic and tactical skill sets needed to direct an important new chapter at ONI.” SOUTH RIDING, Va. (PRWEB) March 13, 2023 Slon... |
| 21.01.2022 | ONI Closes $75M in Series B Funding | Oni, a San Diego, CA- and Oxford, UK-based biotechnology company democratizing the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, closed a $75m Series B financing. The round was led by A... |
| 20.01.2022 | ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital | ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, today announced the closing of a $75 million Series B financing. The round was led by ARCH V... |
| - | ONI Appoints Commercial Expert Patrick Finn, Ph.D., to its Board of Directors to Support Market Expansion for its Single Molecule Microscopy Platform | OXFORD, England--(BUSINESS WIRE)--Mar 25, 2021-- ONI, a rapidly growing company redefining the boundaries of microscopy with its Nanoimager platform that enables imaging of individual molecules in living cells, today announces that Patrick ... |